Alumis (ALMS) EPS (Weighted Average and Diluted) (2023 - 2025)
Alumis (ALMS) reported EPS (Weighted Average and Diluted) of -$0.94 for Q4 2025, down 308.7% year-over-year from $0.45 in Q4 2024, and up 11.32% quarter-over-quarter from -$1.06 in Q3 2025.
Alumis (ALMS) EPS (Weighted Average and Diluted) (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.94 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.94, down 308.7% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.05 (up 93.38% YoY), and the FY2025 annual result was -$2.86, up 72.45% from the prior year.
- EPS (Weighted Average and Diluted) improved to -$0.94 in Q4 2025 per ALMS's latest filing, from -$1.06 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.77 in Q2 2025 and troughed at -$23.1 in Q2 2024.
- A 3-year average of -$9.38 and a median of -$1.82 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 103.33% in 2025 and fell as far as 308.7% in 2025.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$17.1 in 2023, then surged by 98.65% to -$0.23 in 2024, then slumped by 308.7% to -$0.94 in 2025.
- Business Quant data shows ALMS's EPS (Weighted Average and Diluted) at -$0.94 in Q4 2025, -$1.06 in Q3 2025, and $0.77 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | -0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.94 |
| Sep 30, 2025 | -1.06 |
| Jun 30, 2025 | 0.77 |
| Mar 31, 2025 | -1.82 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -1.73 |
| Jun 30, 2024 | -23.10 |
| Mar 31, 2024 | -21.03 |
| Dec 31, 2023 | -17.10 |
| Sep 30, 2023 | -19.76 |
| Jun 30, 2023 | -17.13 |